Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Comparative study of Thymoglobulin and Simulect in kidney transplant rejection closed early

March 19, 2002

Deltagen's drug target DT021I enters development program for inflammatory diseases

March 18, 2002

Phase I results show Product R to be safe and well tolerated

March 15, 2002

Nuvion enters phase II trial in steroid-refractory graft-versus-host disease

March 14, 2002

PowderJect submits MAA for Dukoral cholera and travel diarrhea vaccine

March 13, 2002

Synt:em licenses Pep:trans technology to Corixa for vaccine development

March 13, 2002

AtheroGenics begins phase I trial of transplant rejection drug AGI-1096

March 8, 2002

B7 protein PD-L2 described in patent

March 6, 2002

OrBec receives orphan drug status in Europe for intestinal graft-vs.-host disease

March 4, 2002

Effects on dendritic cell function of the immunomodulator R-848

March 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...